Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy
NCT06709339Phase 4Recruiting
- Sponsor
- AIBILI
- Start
- Aug 2025
- Primary completion
- Aug 2028
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 4 trial of faricimab in polypoidal choroidal vasculopathy (PCV), sponsored by AIBILI. Started Aug 2025; status: recruiting.
02
Drugs
faricimab
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT06709339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06709339.